LifeMD, Inc.
LFMD
$6.09
$0.030.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 43.23% | 38.27% | 40.94% | 33.26% | 59.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.23% | 38.27% | 40.94% | 33.26% | 59.53% |
| Cost of Revenue | 76.07% | 4.85% | 10.48% | 9.14% | 31.66% |
| Gross Profit | 38.78% | 43.00% | 45.35% | 36.78% | 64.25% |
| SG&A Expenses | 28.27% | 37.01% | 41.59% | 42.80% | 31.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 63.09% | 29.48% | 51.13% | 39.99% | 86.83% |
| Total Operating Expenses | 34.46% | 34.49% | 39.48% | 39.85% | 34.46% |
| Operating Income | 146.89% | -2.55% | -28.80% | -116.32% | 68.33% |
| Income Before Tax | 114.47% | 0.73% | -16.05% | -93.14% | 75.08% |
| Income Tax Expenses | -60.40% | -- | -- | -- | 18.66% |
| Earnings from Continuing Operations | 107.28% | -3.67% | -16.05% | -93.14% | 72.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 33.12% | 141.20% | 95.41% | 78.90% | -41.56% |
| Net Income | 97.15% | 16.18% | -2.12% | -68.85% | 68.73% |
| EBIT | 146.89% | -2.55% | -28.80% | -116.32% | 68.33% |
| EBITDA | 176.51% | -0.36% | -29.43% | -127.85% | 71.49% |
| EPS Basic | 82.97% | 29.74% | 19.64% | -27.35% | 69.68% |
| Normalized Basic EPS | 96.58% | 41.88% | 24.84% | -37.15% | 62.72% |
| EPS Diluted | 83.37% | 29.74% | 17.61% | -27.35% | 68.94% |
| Normalized Diluted EPS | 96.58% | 41.88% | 24.84% | -37.15% | 62.72% |
| Average Basic Shares Outstanding | 14.87% | 21.90% | 26.83% | 23.87% | 16.96% |
| Average Diluted Shares Outstanding | 14.87% | 21.90% | 26.83% | 23.87% | 16.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -34.12% | -0.19% | 0.02% | 0.41% | -2.20% |